ARC in SIAL China Fair

ARC in SIAL China Fair

Following our commitment to the F&B industry, ARC Capital, represented by Partners Carlos Lopez and Rui Cavendish and Associate Harry Zhao, attended the SIAL China fair during this week, the main event of its kind in Asia and one of the most important fairs in the world.

With over 3,000 companies from over 100 countries, ARC Capital discussed, during the event that was held in Shanghai, financing, global trends in F&B M&A, met with the Fortune 500 companies from the sector, and scouted potential targets for an upcoming fund that is in the pipeline. SIAL China is the sister event of SIAL, the most prominent F&B fair in Europe, and it has become a mandatory stop in the global food calendar.

ARC Capital has an extensive experience in the F&B industry, as it is one of its core industries, and we look forward to working with the new companies whom we met during the exhibition.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission